Cargando…

Mutated TP53 in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Carcinoma Patients

Circulating tumor DNA (ctDNA) has been suggested as a surrogate biomarker for early detection of cancer recurrence. We aimed to explore the utility of ctDNA as a noninvasive prognostic biomarker in newly diagnosed head and neck squamous cell carcinoma (HNSCC) patients. Seventy HNSCC specimens were a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kampel, Liyona, Feldstein, Sara, Tsuriel, Shlomo, Hannes, Victoria, Carmel Neiderman, Narin N., Horowitz, Gilad, Warshavsky, Anton, Leider-Trejo, Leonor, Hershkovitz, Dov, Muhanna, Nidal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527516/ https://www.ncbi.nlm.nih.gov/pubmed/37759818 http://dx.doi.org/10.3390/biom13091418

Ejemplares similares

The Prognostic Value and Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test in Cutaneous Squamous Cell Carcinoma: Systematic Review and Meta-Analysis
por: Masarwy, Razan, et al.
Publicado: (2023)

Functional outcome following intracapsular resection of head and neck peripheral nerve sheath tumors: a retrospective cohort
por: Kampel, Liyona, et al.
Publicado: (2023)

Extracellular Vesicle-Derived DNA vs. CfDNA as a Biomarker for the Detection of Colon Cancer
por: Thakur, Kavita, et al.
Publicado: (2021)

Endoscopic posterior cordotomy for treatment of dyspnea due to vocal fold immobility
por: Carmel-Neiderman, Narin Nard, et al.
Publicado: (2020)

The Role of Imaging in the Preoperative Assessment of Patients with Nasal Obstruction and Septal Deviation—A Retrospective Cohort Study
por: Carmel-Neiderman, Narin Nard, et al.
Publicado: (2021)

The effect of septal deviation on postoperative quality of life in patients undergoing radiofrequency‐assisted turbinate reduction
por: Carmel Neiderman, Narin N., et al.
Publicado: (2022)

Fast-Tracking of Publication Times of Otolaryngology Papers During the COVID-19 Pandemic
por: Duek, Irit, et al.
Publicado: (2022)

Perineural invasion detection in pancreatic ductal adenocarcinoma using artificial intelligence
por: Borsekofsky, Sarah, et al.
Publicado: (2023)

The risk of PD-L1 expression misclassification in triple-negative breast cancer
por: Ben Dori, Shani, et al.
Publicado: (2022)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

Marked Improvement in Refractory TTP Directly after H. pylori Eradication Therapy
por: Gringauz, Irina, et al.
Publicado: (2016)

p53 in head and neck cancer: Functional consequences and environmental implications of TP53 mutations
por: Peltonen, Jenni K, et al.
Publicado: (2010)

Validation of a smartphone-based Rinne test to detect an air-bone gap
por: Hibscher, Daniel, et al.
Publicado: (2021)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
por: Wang, Haiwei, et al.
Publicado: (2022)

Unilateral Increase of Gustatory Thresholds in Acute Otitis Media: A Pilot Study
por: Klein, Linor, et al.
Publicado: (2023)

Optimisation of TP53 reporters by systematic dissection of synthetic TP53 response elements
por: Trauernicht, Max, et al.
Publicado: (2023)

Integrative Analysis of TP53INP2 in Head and Neck Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2021)

The TP53 fertility network
por: Paskulin, Diego d’Avila, et al.
Publicado: (2012)

TP53: an oncogene in disguise
por: Soussi, T, et al.
Publicado: (2015)

TP53 in Myelodysplastic Syndromes
por: Jiang, Yan, et al.
Publicado: (2021)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
por: Sonkin, Dmitriy
Publicado: (2015)

Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53(null) Cell Lines
por: Silden, Elisabeth, et al.
Publicado: (2013)

Lamotrigine as monotherapy in clinical practice: efficacy of various dosages in epilepsy
por: Warshavsky, Anton, et al.
Publicado: (2016)

TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection
por: Klinakis, Apostolos, et al.
Publicado: (2020)

Redox-sensitive TP53INP1 SUMOylation as an oxidative stress sensor to activate TP53
por: Bonacci, Thomas, et al.
Publicado: (2014)

TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes
por: Yabe, Mariko, et al.
Publicado: (2021)

TP53_PROF: a machine learning model to predict impact of missense mutations in TP53
por: Ben-Cohen, Gil, et al.
Publicado: (2022)

Association between Nuclear Morphometry Parameters and Gleason Grade in Patients with Prostatic Cancer
por: Malshy, Kamil, et al.
Publicado: (2022)

Updates from the TP53 universe
por: Pentimalli, Francesca
Publicado: (2018)

TP53 in Biology and Treatment of Osteosarcoma
por: Synoradzki, Kamil Jozef, et al.
Publicado: (2021)

The Role of TP53 in Adaptation and Evolution
por: Voskarides, Konstantinos, et al.
Publicado: (2023)

Vomiting and Hyponatremia Are Risk Factors for Worse Clinical Outcomes Among Patients Hospitalized Due to Nonsurgical Abdominal Pain: A Retrospective Cohort Study
por: Goren, Idan, et al.
Publicado: (2016)

Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
por: Kyndi, M, et al.
Publicado: (2005)

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes
por: McGraw, K L, et al.
Publicado: (2015)

Comprehensive Identification of Deleterious TP53 Missense VUS Variants Based on Their Impact on TP53 Structural Stability
por: Tam, Benjamin, et al.
Publicado: (2021)

TP53 inhibitor PFTα increases the sensitivity of arsenic trioxide in TP53 wildtype tumor cells
por: Wang, Haiwei, et al.
Publicado: (2022)

p53/TP53 Status Assessment in Gastroesophageal Adenocarcinoma
por: Boldrin, Elisa, et al.
Publicado: (2023)

Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer
por: Lyu, Haoyu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1frjr6q933fv6m986hc99vrcor